Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Validus Cellular Therapeutics logo — Treating Untreatable Infections

Validus Cellular Therapeutics

Treating Untreatable Infections

Founded 2019 United States Aurora, United States 3 employees Debt Financing Total: $20.20K Health Care, Health and Wellness

General Information

Company Name Validus Cellular Therapeutics
Founded Year 2019
Location United States Aurora, United States +1
Employees 3
Industries Health Care, Health and Wellness
Funding Stage Debt Financing
Social

Get notified when Validus Cellular Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Validus Cellular Therapeutics

Validus Cellular Therapeutics is a renowned player in the Health Care industry, offering a groundbreaking solution for chronic resistant infections with its flagship product VCT-101. Unlike traditional antibiotics, VCT-101 boasts a novel preclinical anti-infective therapy that targets infections with a distinct mechanism, reducing susceptibility to resistance. This innovative cell therapy, aimed at bolstering the immune system and facilitating direct bacterial killing, holds promise in treating previously untreatable infections. Founded in 2016 and headquartered in the United States, the company recently secured a $20.20K Debt Financing investment on 11 August 2020. With its revolutionary approach to combating chronic infections, Validus Cellular Therapeutics is poised to make a significant impact in the healthcare landscape.

Taxonomy: antibiotic resistance, cell therapy, infectious diseases, chronic infections, preclinical stage therapy, immune system boosting, orthopedic infections, skin & soft tissue infections, COPD, ARDS, novel anti-infective therapy, bacterial killing mechanism, immune system activation, therapeutic solutions, Validus Cellular Therapeutics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 11 Aug 2020

Validus Cellular Therapeutics Alternatives & Competitors

Validus Cellular Therapeutics vs
Replicor Inc.
Replicor Inc. Canada

292 million people have chronic hepatitis B. We're developing the cure.

6 employees
Biotechnology, Health Care
Validus Cellular Therapeutics vs
ImevaX
ImevaX

Pioneering vaccines to combat chronic and hospital-acquired infections, targeting the mechanisms beh...

Series A
Biotechnology, Health Care
Validus Cellular Therapeutics vs
Optimer Pharmaceuticals
Optimer Pharmaceuticals

A pharmaceutical company committed to advancing anti-infective therapies focused on gastrointestinal...

Series D
Biotechnology, Health Care

FAQ About Validus Cellular Therapeutics

Treating Untreatable Infections
Validus Cellular Therapeutics was founded in 2019.
Validus Cellular Therapeutics is headquartered in Aurora, United States.
Validus Cellular Therapeutics operates in the following industries: Health Care, Health and Wellness.
Validus Cellular Therapeutics has approximately 3 employees.
Validus Cellular Therapeutics has completed 1 funding round, raising a total of $20.20K. The latest funding stage is Debt Financing.
Top alternatives and competitors to Validus Cellular Therapeutics include Replicor Inc., ImevaX, Optimer Pharmaceuticals, Cytheris, Tolerx, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Validus Cellular Therapeutics and Replicor Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Validus Cellular Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes